Global vaccine trials to begin as Ebola and mpox spread in Africa
The Ebola outbreak in the Democratic Republic of the Congo is now the worst in the country's history, with the death toll having reached 3,007 amid an international push to develop vaccines to curb the spread of the disease. At least 6,186 cases have been confirmed in the DR Congo, with infections also spreading across its porous borders. Patients have contracted the Bundibugyo strain of the…
The Ebola outbreak in the Democratic Republic of the Congo has reached its worst level, with a death toll of 3,007 and over 6,186 confirmed cases. The disease has spread to six neighboring regions, and the World Health Organization (WHO) is preparing to test potential vaccines to combat the spread of the Bundibugyo strain. Meanwhile, the mpox outbreak, which began in 2022, has affected approximately 145 countries, resulting in 190,683 cases and 529 deaths.
Both diseases have distinct modes of transmission, with mpox spreading through close skin-to-skin contact and Ebola through contact with blood, bodily fluids, or contaminated surfaces. A global initiative to establish a stockpile of mpox vaccines was launched on August 27 to ensure access for lower-income countries. The UAE has played a significant role in funding and distributing vaccines to African nations facing Ebola and mpox crises, including the DRC, Nigeria, South Africa, Ivory Coast, and Cameroon.
Written by urgent.news from The National UAE's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
